SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$1.47 USD
-0.02 (-1.01%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $1.46 -0.01 (-0.34%) 7:34 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for SCYNEXIS, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 140 | 5 | 13 | 0 | 0 |
Cost Of Goods | 16 | 1 | 0 | 0 | 0 |
Gross Profit | 125 | 4 | 13 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 52 | 90 | 74 | 51 | 49 |
Income After Depreciation & Amortization | 73 | -86 | -61 | -51 | -49 |
Non-Operating Income | -2 | 23 | 28 | -6 | -4 |
Interest Expense | 3 | 5 | 3 | 1 | 1 |
Pretax Income | 67 | -68 | -36 | -58 | -54 |
Income Taxes | 0 | -5 | -3 | -3 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 67 | -63 | -33 | -55 | -54 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 67 | -63 | -33 | -55 | -54 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 76 | -84 | -59 | -50 | -48 |
Depreciation & Amortization (Cash Flow) | 4 | 2 | 2 | 1 | 1 |
Income After Depreciation & Amortization | 73 | -86 | -61 | -51 | -49 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.39 | 42.61 | 26.39 | 10.72 | 5.61 |
Diluted EPS Before Non-Recurring Items | 1.39 | -1.47 | -1.25 | -4.71 | -8.10 |
Diluted Net EPS (GAAP) | 1.39 | -1.47 | -1.25 | -5.15 | -9.60 |
Fiscal Year end for SCYNEXIS, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.74 | 1.37 | 5.80 | 1.76 | 131.45 |
Cost Of Goods | 0.00 | 0.00 | 14.68 | 0.38 | 0.43 |
Gross Profit | 0.74 | 1.37 | -8.89 | 1.38 | 131.03 |
SG&A, R&D, and Dept/Amort Expenses | 9.98 | 10.88 | 14.18 | 11.48 | 14.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | -9.24 | -9.51 | -23.07 | -10.10 | 116.52 |
Non-Operating Income | -5.02 | 10.66 | 3.84 | 8.55 | 7.00 |
Interest Expense | 0.20 | 0.21 | 0.22 | 0.21 | 1.25 |
Pretax Income | -14.46 | 0.94 | -19.45 | -1.76 | 122.26 |
Income Taxes | 0.00 | 0.53 | 0.14 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -14.46 | 0.41 | -19.59 | -1.76 | 122.26 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -14.46 | 0.41 | -19.59 | -1.76 | 122.26 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 48.51 | 48.57 | 50.22 | 47.89 | 49.92 |
Diluted EPS Before Non-Recurring Items | -0.30 | -0.15 | -0.39 | -0.04 | 2.46 |
Diluted Net EPS (GAAP) | -0.30 | 0.01 | -0.32 | -0.04 | 2.46 |